I've folowed OSL for a few years now and recently bought back in at ~14c. Following CE mark approval and providing the data from ongoing trials continues to be positive I wouldn't be surprised to see a take-over on the horizon. Still a significant amount of work to do but I now see some short term catalysts which should help drive share price momentum. Remains a high risk high reward play.